MENU
TNGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tango Therapeutics (TNGX) Ownership - Who owns Tango Therapeutics?
Profile
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 857 320-4900
Employees
140
Web
https://www.tangotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
312.59M
P/E Ratio
N/A
Total Cash
293.28M
Projected Growth
N/A
Total Debt
37.63M
Revenue
43.38M
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash/Share
2.73
Total Debt/Equity
N/A
Revenue/Share
0.40 USD as % of share price
Fundamentals
TNGX
Capitalization
313M
P/E Ratio
N/A
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash
293M
Total Cash/Share
2.73
Total Debt
37.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.40%
Revenue
43.4M
ROE
N/A
Book Value
229M
P/B Ratio
1.36
Cash Flow
N/A
Earnings
-1.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
107K
Current Ratio
8.00
Current Revenue Per Employee
82907.14
Dividends Per Share - Security
N/A
EBITDA
-137.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.62
Shares Held By Institutions
944M
Shares Outstanding - Current
107M
Total Liabilities
123M
Total Volume MTD
N/A
Value
1
Gain YTD
-70.606
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 857 320-4900
Employees
140
Web
https://www.tangotx.com